Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Sanofi receives SEC recommendation to bring new therapies of Pompe, ASMD to India
The company hopes to launch these therapies in India by end of 2023 or beginning of next year, subject to completion of all…
Biliary tract cancer drug Durvalumab approval key opportunity for AstraZeneca in India: GlobalData
Imfinzi is the only immunotherapy-based combination treatment option in India that offers significantly improved survival rates in…
Venus Remedies gets Saudi GMP approval for production facilities in Baddi
Venus Remedies has received three additional facility approvals and successfully renewed four existing facility approvals from…
Dr Reddy’s to acquire Mayne Pharma’s US generic prescription product portfolio
Dr Reddy's Laboratories has entered into a definitive agreement to acquire the US generic prescription product portfolio of…
Novel pipeline therapies to drive diabetic neuropathic pain market across 7MM to $3 bn in 2031:…
The growth will be driven by the potential introduction of four promising late-stage pipeline products and an increase in the…
Aster launches 250th pharmacy in India
Aster has added its 250th location in 23 months. Now operating in Karnataka, Kerala, Telangana and Andhra Pradesh, Aster Pharmacy…
Redx, Jounce announce recommended business combination
Combined group will have a strong clinical pipeline and proven expertise in the discovery and development of highly selective…
IMC to organise conference on ‘Health, Wellness and Workplaces’
The aim of this conference is to get all stakeholders of corporate India’s wellness to define the path ahead. People with a stake…
Strides’ Bangalore facility gets EIR from USFDA
The company’s flagship facility was inspected by the USFDA between December 5 and 9, 2022, and a form 483 listing three…
Rajkumar Shirodkar, Sr VP, Sovereign Pharma
Daman Pharma Summit 2023 | 20th January 2023 | The Deltin, Daman